Dharma Research, Inc.
FDA inspection history in Miami, Florida, 2019 to 2026
- 4
- Form 483s
Every document, by year
- Form 483
2019: one Form 483; 2022: one Form 483; 2024: one Form 483; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Miami, Florida.
- 2019The longest 483 on file: 12 observations over 8 pages at Miami, Florida.
- 2022–26Three Form 483s, at Miami, Florida.
Cited most
Across all Dharma Research observations on file
- 21 CFR 820.30Design controls3
- 21 CFR 820.100(a)Corrective and preventive action2
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.165(b)Testing and release for distribution1
The complete Dharma Research file.
All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Miami, Florida
Four Form 483s · 2019 to 2026 · 21 observations
Latest: Form 483, Mar 13, 2026 →
Documents
4 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-03-13 | 483 Form 483 | Miami, Florida | 1 | $99 |
| 2024-12-11 | 483 Form 483 | Miami, Florida | 3 | $99 |
| 2022-09-30 | 483 Form 483 | Miami, Florida | 5 | $99 |
| 2019-03-18 | 483 Form 483 | Miami, Florida | 12 | $99 |
Investigators on these documents
Ronald Ifraimov (2)Dianiris C. Ayala (1)Jamirya S. Weatherly (1)
FEI number 3010131268 · most recent document Mar 13, 2026
About Dharma Research, Inc.
How many FDA Form 483s has Dharma Research, Inc. received?
FDA Intel has 4 Form 483s on file for Dharma Research, Inc.; the most recent is dated Mar 13, 2026.
When was Dharma Research, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Dharma Research, Inc. is a Form 483 dated Mar 13, 2026, for the site in Miami, Florida.
What did FDA cite at Dharma Research, Inc.?
The regulations cited most in the observations on file for Dharma Research, Inc. are 21 CFR 820.30 (Design controls), 3 times; 21 CFR 820.100(a) (Corrective and preventive action), 2 times; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time.